CD274 and precursor B-cell acute lymphoblastic leukemia: This model of B-ALL expresses high levels of the checkpoint ligand PD-L1 (Fig. 5d), and PD-L1 expression has previously been implicated in B-ALL resistance to immune-stimulating therapy40.